What's your pain IQ? Find out with this 12-question round-up from popular Patient Care pain quizzzes.
FDA Accepts Vertex NDA for Suzetrigine, Investigational Oral Nonopioid Analgesic for Acute pain
If approved the selective NaV1.8 pain signal inhibitor would reflect the first new class of pain management medication in more than 20 years.
Obesity & Pain Management: A Primary Viewpoints Podcast
In our latest episode, an obesity medicine physician explains the importance of a comprehensive plan to manage chronic pain in patients with obesity.
Hip Pain in a Man with Type 1 Diabetes: Seen in the ED
Patient is in his forties; pain has been waxing, waning, worsening for 2 weeks. He has no other significant medical history. Do lab results hold clues? What's your Dx?
Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.
Atogepant vs Rimegepant for Migraine Prevention: Daily Dose
Your daily dose of the clinical news you may have missed.
Atogepant Found More Effective for Migraine Prevention vs Rimegepant in New Analysis
Atogepant was associated with fewer monthly migraine days, fewer acute medication use days, and greater QoL compared with rimegepant after 12 weeks.